openPR Logo
Press release

Global Chromosomal Aberration Test Market Expected to Secure Notable Revenue Share during 2018-2026|| Top Market players- Charles River Laboratories Inc., Covance Inc., Molecular Toxicology, Environmental bio-detection products inc., Thermo Fisher Scienti

11-21-2018 12:15 PM CET | Health & Medicine

Press release from: Fact.MR

Global Chromosomal Aberration Test Market Expected to Secure

Chromosomal aberration is a structural abnormality in one or more chromosomes. Several mutagenic agents are frequently exposed to the human population, they have potential to damage the DNA. In many cases result in the form of chromosomal aberration. Chromosomal aberration is majorly 4 type deletion, duplication, inversion, and translocation. Induced chromosomal aberrations can be classified into two main classes - chromosome type aberration and chromatids type aberrations. Chromosomal aberration includes rearrangement, breakage and numerical changes which play important role in cancer formation, heritable mutation, developmental abnormalities and embryonic loss. The most common type of chromosomal abnormality is aneyploidy. Chromosomal aberration test procedures importance is increasing with time for determination of genetic risk, DNA, and chromosomal structure changes. Chromosomal aberration tests performed in vitro and in vivo which are designed to detect compounds that include DNA damage. Basically test using mammalian cells is used to identify causative agents of structural changes in chromosomes.  Chromosomal aberration test involves the real-time analysis of chromosomes to identify structural and sequential variation. 

Request for Brochure of this Report: https://www.factmr.com/connectus/sample?flag=B&rep_id=1160

Increasing awareness about chromosomal aberration test among people suffering from genetic and chromosomal disorders is expected to drive the demand of Chromosomal Aberration Test Market. Growing number of people suffering from genetic disorders are expected to increase demand for chromosomal aberration testing procedures in order to have a healthy baby.  Increasing application for chromosomal aberration testing for the diagnosis of disorders like minor disabilities like deafness and cancer expected to create high growth opportunities for chromosomal aberration test market players. Increasing birth abnormalities, adoption of genetic counseling, increasing rate of prenatal diagnosis and fertility treatment are some of the major driving factors of chromosomal aberration test market. Adoption of the point of care testing for quick diagnosis and guiding to doctor are expected to boost the demand of chromosomal aberration testing among healthcare professionals. There are some technical limitations like the higher cost of services, failure to detect abnormal results, standardization and poor test results in case of the contaminated sample. The high cost of testing and limited reimbursement policies is restraining the growth of chromosomal aberration test market.

The global chromosomal aberration test market is segmented on basis of test type, end user and region:

Segmentation by Test Type
Mammalian Chromosome Aberration Test
Genetic Toxicity Testing
Cytogenetic Testing
Bacterial Reverse Mutation Test

Segmentation by End User
Hospitals
Diagnosis Laboratories
Fertility and Maternity Centers
Research Centers

Chromosomal aberration test is designed to evaluate the potential of test to induce chromosomal abnormalities such as exchanges and breaks. Chromosomal aberration assays are also used to detect chemicals that induce chromosome damage, including complex chromosome change such as rings, exchanges & dicentrics and chromatid & chromosome breaks. The global chromosomal aberration market is expected to witness high growth over forecast period owing to increasing number of the treatment-seeking rate for the genetic problem or avoiding birth defects problems among babies.

Browse full details about Chromosomal Aberration Test Market report: https://www.factmr.com/report/1160/chromosomal-aberration-test-market

Some of the players operating in the global chromosomal aberration test market are Charles River Laboratories, Inc., Covance Inc., Molecular Toxicology, Inc., Environmental bio-detection products inc., Thermo Fisher Scientific, F. Hoffmann-La Roche Ltd, Abbott Laboratories and others.

Regional Analysis:
North America
Latin America
Europe
Asia Pacific Excluding China
China
Middle East & Africa

Report Highlights:
Shifting industry dynamics
In-depth market segmentation
Historical, current and projected industry size recent industry trends
Key competition landscape
Strategies of key players and product offerings
Potential and niche segments/regions exhibiting promising growth
A neutral perspective towards market performance

Make an inquiry for purchasing this report: https://www.factmr.com/connectus/sample?flag=AE&rep_id=1160

About FactMR
FactMR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market insights reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that's why we publish multi-industry global, regional, and country-specific research reports.

Contact Us
Fact.MR
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Email: sales@factmr.com
Web: https://www.factmr.com/
Blog: https://factmrblog.com/
Read Industry News at - https://www.industrynewsanalysis.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Chromosomal Aberration Test Market Expected to Secure Notable Revenue Share during 2018-2026|| Top Market players- Charles River Laboratories Inc., Covance Inc., Molecular Toxicology, Environmental bio-detection products inc., Thermo Fisher Scienti here

News-ID: 1388838 • Views:

More Releases from Fact.MR

Intelligent Transport System Market is Evaluatedto Reach USD 63.77 Billion by 2034 | Fact.MR
Intelligent Transport System Market is Evaluatedto Reach USD 63.77 Billion by 20 …
Fact.MR today released its latest report on the Intelligent Transport System (ITS) Market, projecting robust growth driven by increasing urbanization, rising demand for efficient traffic management, and advancements in smart mobility technologies. Valued at USD 30.66 billion in 2024, the global market is forecasted to expand at a compound annual growth rate (CAGR) of 7.6%, reaching USD 63.77 billion by 2034. This significant growth underscores the critical role of ITS
Digital Door Lock System Market is Growing at a CAGR of 16% by 2034 | Key Players: Honeywell International Inc., Godrej & Boyce Manufacturing Company Ltd., and Samsung Electronics Co Ltd
Digital Door Lock System Market is Growing at a CAGR of 16% by 2034 | Key Player …
Digital Door Lock System Market is valued at USD 11 billion in 2024 and is projected to expand at a compound annual growth rate (CAGR) of 16%, reaching USD 48.7 billion by 2034. This remarkable growth is driven by the increasing popularity of smart homes, which integrate advanced security features for enhanced convenience and protection. Digital door lock systems, utilizing technologies like biometrics and wireless connectivity, offer keyless entry, remote
Electronic Access Control Systems Market is Estmated to Reach USD 32.5 Billion by 2033 | Key Players: Cisco Systems, Siemens AG, Honeywell International Inc., Robert Bosch GmbH, Schneider Electric SE
Electronic Access Control Systems Market is Estmated to Reach USD 32.5 Billion b …
The global electronic access control systems market is valued at USD 14.64 billion in 2023 and is projected to expand at a compound annual growth rate (CAGR) of 8.3%, reaching USD 32.5 billion by 2033. This growth is driven by the increasing need for advanced security solutions amid rising threats of terrorism, break-ins, and data breaches. Electronic access control systems, encompassing biometrics, card-based, keypad, intruder alarm, and perimeter security technologies,
Neurology Devices Market is Estimated to Reach USD 22,335.5 Million by 2035 | Fact.MR Report
09-01-2025 | Health & Medicine
Fact.MR
Neurology Devices Market is Estimated to Reach USD 22,335.5 Million by 2035 | Fa …
Neurology Devices Market was valued at USD 10,944.3 million in 2024 and is forecasted to expand at a CAGR of 6.7%, reaching USD 22,335.5 million by 2035. This growth reflects the increasing demand for advanced diagnostic and therapeutic tools to address neurological disorders, including Alzheimer's disease, Parkinson's disease, major depression, epilepsy, spinal cord injury, and traumatic brain injury. Neurology devices play a crucial role in diagnosing, preventing, and treating these

All 5 Releases


More Releases for Chromosomal

Best Research Report on Chromosomal Microarray (CMA) Testing Market With Covid-1 …
"Stratagem Market Insights offers a 70% discount on Chromosomal Microarray (CMA) Testing Market Reports on Single User Access and Unlimited User Access" Overview Chromosomal Microarray (CMA) Testing Market 2022 Forecast to 2030 research provides accurate economic, global, and country-level predictions and analyses. It provides a comprehensive perspective of the competitive market as well as an in-depth supply chain analysis to assist businesses in identifying major changes in industry practices. The market report
Profitable Strategic Report on Chromosomal Microarray Analysis (CMA) Testing Mar …
Worldwide "Chromosomal Microarray Analysis (CMA) Testing Market" 2022 Research Report presents a professional and complete analysis of the Global Chromosomal Microarray Analysis (CMA) Testing Market in the current situation. This report includes development plans and policies along with Chromosomal Microarray Analysis (CMA) Testing manufacturing processes and price structures. the reports 2022 research report offers an analytical view of the industry by studying different factors like Chromosomal Microarray Analysis (CMA) Testing
Chromosomal Microarray Market Trends and Forecast Report 2022 - by Players, Type …
The Global and United States Chromosomal Microarray Market Report has been published by QY Research recently. Chromosomal Microarray Market Analysis and Insights This report focuses on global and United States Chromosomal Microarray market, also covers the segmentation data of other regions in regional level and county level. Chromosomal Microarray market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Chromosomal Microarray market will
Doppler Ultrasound Systems find its Use for Obstetrics Imaging; nearly one in 15 …
Doppler ultrasound applications form an essential imaging tool in a range of clinical conditions. Doppler ultrasound which is a noninvasive test has been instrumental in diagnosing poorly functioning valves in the leg veins, a blocked artery, decreased blood circulation into the legs and blood clots and aneurysms. Doppler ultrasound has been used as an alternative to more-invasive procedures—angiography—that involves injecting dye into the blood vessels. These actionable insights are according
07-25-2018 | Health & Medicine
Fact.MR
Global Chromosomal Aberration Test Market Cost Structure, Supply, Demand, Key Re …
Chromosomal aberration is a structural abnormality in one or more chromosomes. Several mutagenic agents are frequently exposed to the human population, they have potential to damage the DNA. In many cases result in the form of chromosomal aberration. Chromosomal aberration is majorly 4 type deletion, duplication, inversion, and translocation. Induced chromosomal aberrations can be classified into two main classes - chromosome type aberration and chromatids type aberrations. Chromosomal aberration includes
Non-invasive Prenatal Testing Market to Grow at 17.50% CAGR from 2014 and 2022 d …
According to the research report’s estimates, the global non-invasive prenatal testing market was worth US$0.5 bn in 2013 and is expected to grow at an incredible CAGR of 17.50% from 2014 to 2022 to reach a figure of US$2.4 bn by 2022. The impressive growth of the global non-invasive prenatal testing market is mainly due to the growing chances of fetuses developing chromosomal disorders such as Down syndrome, Turner syndrome,